protein kinase inhibitors (Kinetix)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameprotein kinase inhibitors (Kinetix)
Drug Alias NameVEGFR-2 inhibitors (Kinetix)anti-inflammatories (Kinetix)AKT inhibitors (Kinetix)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene proteins c-akt inhibitorsVascular endothelial growth factor receptor antagonists
TargetsProto-oncogene proteins c-aktVascular endothelial growth factor receptor
Therapy Area/IndicationsInflammationHypersensitivityAsthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKinetix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer InstituteKinetix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityAsthma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A